# Franklin BSP Realty Trust, Inc.: financial statements, quarterly

FBRT · NYSE · CIK 1562528 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fbrt.md) · [Financials](/companies/fbrt/financials.md) · [Filings](/companies/fbrt/filings.md) · [Insiders](/companies/fbrt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fbrt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.0 d](/filings/0001562528-26-000008.md) | [4.7](/filings/0001562528-25-000019.md) | [4.1](/filings/0001562528-25-000030.md) | [5.4](/filings/0001562528-24-000034.md) | [8.7 d](/filings/0001562528-26-000008.md) | [6.8](/filings/0001562528-25-000019.md) | [8.3](/filings/0001562528-25-000030.md) | [89.5](/filings/0001562528-26-000033.md) | [(164) d](/filings/0001562528-26-000008.md) | [74.4](/filings/0001562528-26-000014.md) | [65.3](/filings/0001562528-26-000024.md) | [74.9](/filings/0001562528-26-000033.md) |
| Interest expense | $m | [81.2 d](/filings/0001562528-24-000008.md) | [81.3](/filings/0001562528-24-000016.md) | [86.7](/filings/0001562528-24-000025.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.3) d](/filings/0001562528-26-000008.md) | [0.8](/filings/0001562528-25-000019.md) | [(0.1)](/filings/0001562528-25-000030.md) | [0.2](/filings/0001562528-25-000041.md) | [0.2 d](/filings/0001562528-26-000008.md) | [0.7](/filings/0001562528-26-000014.md) | [(0.1)](/filings/0001562528-26-000024.md) | [(2.9)](/filings/0001562528-26-000033.md) | [6.3 d](/filings/0001562528-26-000008.md) | [0.9](/filings/0001562528-26-000014.md) | [(2.9)](/filings/0001562528-26-000024.md) | [(8.0)](/filings/0001562528-26-000033.md) |
| Net income | $m | [30.0 d](/filings/0001562528-26-000008.md) | [35.9](/filings/0001562528-25-000041.md) | [(2.2)](/filings/0001562528-25-000041.md) | [31.6](/filings/0001562528-25-000041.md) | [30.5 d](/filings/0001562528-26-000008.md) | [24.1](/filings/0001562528-26-000033.md) | [23.2](/filings/0001562528-26-000033.md) | [17.3](/filings/0001562528-26-000033.md) | [17.7 d](/filings/0001562528-26-000008.md) | [12.0](/filings/0001562528-26-000033.md) | [15.6](/filings/0001562528-26-000033.md) | [(26.7)](/filings/0001562528-26-000033.md) |
| Diluted EPS | $ per share | not reported | [0.35](/filings/0001562528-25-000019.md) | [(0.11)](/filings/0001562528-25-000030.md) | [0.30](/filings/0001562528-25-000041.md) | not reported | [0.20](/filings/0001562528-26-000014.md) | [0.19](/filings/0001562528-26-000024.md) | [0.12](/filings/0001562528-26-000033.md) | not reported | [0.07](/filings/0001562528-26-000014.md) | [0.12](/filings/0001562528-26-000024.md) | [(0.41)](/filings/0001562528-26-000033.md) |
| Basic EPS | $ per share | not reported | [0.35](/filings/0001562528-25-000019.md) | [(0.11)](/filings/0001562528-25-000030.md) | [0.30](/filings/0001562528-25-000041.md) | not reported | [0.20](/filings/0001562528-26-000014.md) | [0.19](/filings/0001562528-26-000024.md) | [0.12](/filings/0001562528-26-000033.md) | not reported | [0.07](/filings/0001562528-26-000014.md) | [0.12](/filings/0001562528-26-000024.md) | [(0.41)](/filings/0001562528-26-000033.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [338](/filings/0001562528-26-000008.md) | [240](/filings/0001562528-25-000019.md) | [94.8](/filings/0001562528-25-000030.md) | [346](/filings/0001562528-25-000041.md) | [184](/filings/0001562528-26-000033.md) | [215](/filings/0001562528-26-000014.md) | [414](/filings/0001562528-26-000024.md) | [117](/filings/0001562528-26-000033.md) | [167](/filings/0001562528-26-000033.md) | [116](/filings/0001562528-26-000014.md) | [136](/filings/0001562528-26-000024.md) | [101](/filings/0001562528-26-000033.md) |
| Total assets | $m | [5,955](/filings/0001562528-26-000008.md) | [6,028](/filings/0001562528-24-000016.md) | [6,269](/filings/0001562528-24-000025.md) | [6,335](/filings/0001562528-24-000034.md) | [6,002](/filings/0001562528-26-000008.md) | [5,654](/filings/0001562528-25-000019.md) | [5,630](/filings/0001562528-25-000030.md) | [6,218](/filings/0001562528-25-000041.md) | [6,057](/filings/0001562528-26-000033.md) | [6,301](/filings/0001562528-26-000014.md) | [6,384](/filings/0001562528-26-000024.md) | [6,025](/filings/0001562528-26-000033.md) |
| Total liabilities | $m | [4,279](/filings/0001562528-25-000013.md) | [4,353](/filings/0001562528-24-000016.md) | [4,636](/filings/0001562528-24-000025.md) | [4,721](/filings/0001562528-24-000034.md) | [4,393](/filings/0001562528-26-000008.md) | [4,059](/filings/0001562528-25-000019.md) | [4,045](/filings/0001562528-25-000030.md) | [4,563](/filings/0001562528-25-000041.md) | [4,436](/filings/0001562528-26-000033.md) | [4,731](/filings/0001562528-26-000014.md) | [4,835](/filings/0001562528-26-000024.md) | [4,583](/filings/0001562528-26-000033.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,559](/filings/0001562528-25-000013.md) | [1,558](/filings/0001562528-24-000016.md) | [1,519](/filings/0001562528-24-000025.md) | [1,516](/filings/0001562528-24-000034.md) | [1,513](/filings/0001562528-26-000008.md) | [1,500](/filings/0001562528-25-000019.md) | [1,489](/filings/0001562528-25-000030.md) | [1,472](/filings/0001562528-25-000041.md) | [1,442](/filings/0001562528-26-000033.md) | [1,391](/filings/0001562528-26-000014.md) | [1,373](/filings/0001562528-26-000024.md) | [1,346](/filings/0001562528-26-000033.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [55.9 d](/filings/0001562528-26-000008.md) | [13.0](/filings/0001562528-25-000019.md) | [1.9 d](/filings/0001562528-25-000030.md) | [97.4 d](/filings/0001562528-25-000041.md) | [(55.1) d](/filings/0001562528-26-000008.md) | [116](/filings/0001562528-26-000014.md) | [11.8 d](/filings/0001562528-26-000024.md) | [(148) d](/filings/0001562528-26-000033.md) | [312 d](/filings/0001562528-26-000008.md) | [(54.0)](/filings/0001562528-26-000014.md) | [48.3 d](/filings/0001562528-26-000024.md) | [(89.7) d](/filings/0001562528-26-000033.md) |
| Dividends paid | $m | [36.2 d](/filings/0001562528-26-000008.md) | [36.1](/filings/0001562528-25-000019.md) | [36.3 d](/filings/0001562528-25-000030.md) | [36.2 d](/filings/0001562528-25-000041.md) | [36.2 d](/filings/0001562528-26-000008.md) | [36.2](/filings/0001562528-26-000014.md) | [36.4 d](/filings/0001562528-26-000024.md) | [36.5 d](/filings/0001562528-26-000033.md) | [36.4 d](/filings/0001562528-26-000008.md) | [36.0](/filings/0001562528-26-000014.md) | [21.6 d](/filings/0001562528-26-000024.md) | [21.3 d](/filings/0001562528-26-000033.md) |
| Share repurchases | $m | [3.3 d](/filings/0001562528-26-000008.md) | [1.9](/filings/0001562528-25-000019.md) | [3.0 d](/filings/0001562528-25-000030.md) | [0.0 d](/filings/0001562528-25-000041.md) | [0.0 d](/filings/0001562528-26-000008.md) | [0.0](/filings/0001562528-26-000014.md) | [0.0 d](/filings/0001562528-26-000024.md) | [0.0 d](/filings/0001562528-26-000033.md) | [14.4 d](/filings/0001562528-26-000008.md) | [39.8](/filings/0001562528-26-000014.md) | [16.0 d](/filings/0001562528-26-000024.md) | [60.5 d](/filings/0001562528-26-000033.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [82.8](/filings/0001562528-24-000016.md) | [82.3](/filings/0001562528-24-000025.md) | [82.2](/filings/0001562528-24-000034.md) | [82.0](/filings/0001562528-25-000019.md) | [81.8](/filings/0001562528-25-000030.md) | [81.8](/filings/0001562528-25-000041.md) | [82.1](/filings/0001562528-26-000014.md) | [82.2](/filings/0001562528-26-000024.md) | [90.6](/filings/0001562528-26-000033.md) | [79.9](/filings/0001562528-26-000014.md) | [84.8](/filings/0001562528-26-000024.md) | [80.8](/filings/0001562528-26-000033.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 75,672,895 at 2026-10-26, from the cover of the [10-Q filed 2026-10-28](/filings/0001562528-26-000033.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 12:55 ET. No prices; not investment advice.